Inactive Instrument

Press Releases Terumo Corporation Other OTC

Equities

TRUMY

US88156J1051

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView Monitoring System	05-29	AQ
Terumo : NICE PUBLISHES A GUIDANCE SUPPORTING THE USE OF SELECTIVE INTERNAL RADIATION THERAPY FOR NEUROENDOCRINE TUMORS WITH LIVER METASTATIS	05-16	PU
Terumo : Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024	05-16	PU
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023)(with note)	05-15	PU
Terumo : The Future of Terumo "Our vision and the path to it"	05-14	PU
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024	05-14	PU
Terumo : Appoints the Candidates for Directors	05-14	PU
IceCure Medical CEO Issues Letter to Shareholders and Reports Increase in Sales in Preliminary Unaudited 2023 Results	01-11	AQ
Terumo : Blood and Cell Technologies takes part in Connecting the DotsA new film series showcasing the pivotal role of medical technologies to improve healthcare	12-06	PU
Terumo : expands global presence with new subsidiary in South-Africa	11-30	PU
MicroVention Celebrates 10-Year Anniversary and Legacy of SOFIA™ Aspiration Catheters; More than 500,000 Procedures Performed Worldwide Across 170 Countries	11-16	BU
Terumo : India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes	11-16	PU
Terumo : Olympus and Terumo Announce Change in Form of Contract	23-10-31	PU
Terumo : Blood and Cell Technologies launches study with BioCentriq® to generate public CAR-T cell data using Terumo BCT’s CGT manufacturing platformsData will detail how the Terumo BCT’s Quantum Flex® Cell Expansion System and Finia® Fill and Finish System with BioCentriq’s LEAP™ Advanced Therapy Platform can help accelerate delivery of CAR-T therapies to patients	23-10-05	PU
ANGIO-SEAL™ VIP & FEMOSEAL™ VASCULAR CLOSURE DEVICES SECURED CE CERTIFICATE UNDER THE NEW MEDICAL DEVICE REGULATIONTerumo (TSE: 4543) is proud to announce that both of our Vascular Closure Devices, Angio-Seal™ VIP & Femoseal™, received the EU MDR certifications.	23-10-05	PU
Terumo : to Cease Distributing Dexcom Continuous Glucose Monitoring Systems as Dexcom Moves to a Direct Distribution Model in Japan	23-10-02	PU
MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter	23-09-21	BU
Terumo : Financial Results for the First Quarter of Fiscal Year Ending March 31, 2024 (FY2023)(with note)	23-08-10	PU
Terumo : IFRS Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024	23-08-09	PU
Terumo : Financial Results for the First Quarter of Fiscal Year Ending March 31, 2024 (FY2023)	23-08-09	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Terumo Corporation Other OTC

Equities

TRUMY

US88156J1051

Press Releases

Filters